60 Results

People

  1. Kris
    Kris
  2. Riely
    Riely
  3. Rosenzweig
    Rosenzweig
  4. Drilon
    Drilon
  5. Hellmann
    Hellmann
  6. Sima
    Sima
  7. Travis
    Travis
  8. Jones
    Jones
  9. Leibel
    Leibel
  10. Chaft
    Chaft

Groups

  1. Department of Medicine (33)
  2. Solid Tumor Oncology Division (31)
  3. Thoracic Oncology (31)
  4. Surgery (12)
  5. Department of Pathology and Laboratory Medicine (9)
  6. GSK Faculty (8)
  7. Epidemiology and Biostatistics (6)
  8. Sloan Kettering Institute Postdocs (6)
  9. Medical Physics (5)
  10. Radiation Oncology, Department of (5)
  1. "non-small-cell lung cancer"
Formats
  1. Journal Article (53)
  2. Review (4)
  3. Conference Paper (1)
  4. Editorial (1)
  5. Meeting Abstract (1)
Groups
  1. Department of Medicine (33)
  2. Solid Tumor Oncology Division (31)
  3. Thoracic Oncology (31)
  4. Surgery (12)
  5. Department of Pathology and Laboratory Medicine (9)
  6. GSK Faculty (8)

More Groups

People
  1. Mark Kris (9)
  2. Gregory Riely (8)
  3. Kenneth Rosenzweig (8)
  4. Alexander Drilon (6)
  5. Camelia Sima (6)
  6. Matthew Hellmann (6)

More People

Years
  1. 2025 (2)
  2. 2024 (5)
  3. 2023 (1)
  4. 2022 (2)
  5. 2021 (4)
  6. 2020 (4)

More Years

Publications
  1. Annals of Oncology (14)
  2. International Journal of Radiation Oncology, Biology, Physics (10)
  3. Journal of Thoracic Oncology (8)
  4. Future Oncology (6)
  5. European Journal of Cardio-Thoracic Surgery (5)
  6. Lung Cancer (3)

More Publications

Publishers
  1. Elsevier Inc. (20)
  2. Oxford University Press (19)
  3. Future Medicine (7)
  4. Elsevier Ireland Ltd. (3)
  5. Lippincott Williams & Wilkins (2)
  6. MDPI (2)

More Publishers

Results (60)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Monitoring peripheral blood data supports the prediction of immunotherapy response in advanced non-small cell lung cancer based on real-world data
    Journal Article

    Ramos-Guerra, A. D.; Farina, B.; Rubio Pérez, J.; Vilalta-Lacarra, A.; Zugazagoitia, J.; Peces-Barba, G.; Seijo, L. M.; Paz-Ares, L.; Gil-Bazo, I.; Dómine Gómez, M.; more...
    Cancer Immunology, Immunotherapy (2025)

    Fulltext@MSK | Save
  • Lung adenocarcinomas with mucinous histology: clinical, genomic, and immune microenvironment characterization and outcomes to immunotherapy-based treatments and KRASG12C inhibitors
    Journal Article

    Di Federico, A.; Hong, L.; Elkrief, A.; Thummalapalli, R.; Cooper, A. J.; Ricciuti, B.; Digumarthy, S.; Alessi, J. V.; Gogia, P.; Pecci, F.; more...
    Annals of Oncology (2025)

    Fulltext@MSK | Save
  • Lung cancer research and treatment: Global perspectives and strategic calls to action
    Review

    Meyer, M. L.; Peters, S.; Mok, T. S.; Lam, S.; Yang, P. C.; Aggarwal, C.; Brahmer, J.; Dziadziuszko, R.; Felip, E.; Ferris, A.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Intrapatient variation in PD-L1 expression and tumor mutational burden and the impact on outcomes to immune checkpoint inhibitor therapy in patients with non-small-cell lung cancer
    Journal Article

    Di Federico, A.; Alden, S. L.; Smithy, J. W.; Ricciuti, B.; Alessi, J. V.; Wang, X.; Pecci, F.; Lamberti, G.; Gandhi, M. M.; Vaz, V. R.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • A plain language summary of the PHAROS study: The combination of encorafenib and binimetinib for people with BRAF V600E-mutant metastatic non-small-cell lung cancer
    Review

    Riely, G. J.; Smit, E. F.; Ahn, M. J.; Felip, E.; Ramalingam, S. S.; Tsao, A.; Johnson, M.; Gelsomino, F.; Esper, R.; Nadal, E.; more...
    Future Oncology (2024)

    Fulltext@MSK | Save
  • Quantitative MRI evaluation of ferritin overexpression in non-small-cell lung cancer
    Journal Article

    Singhania, M.; Zaher, A.; Pulliam, C. F.; Bayanbold, K.; Searby, C. C.; Schoenfeld, J. D.; Mapuskar, K. A.; Fath, M. A.; Allen, B. G.; Spitz, D. R.; more...
    International Journal of Molecular Sciences (2024)

    Fulltext@MSK | Save
  • A brief report on the patterns of mediastinal nodal failure in resectable stage IB-IIIA NSCLC treated with neoadjuvant immunotherapy combinations, a secondary analysis of a prospective trial
    Journal Article

    Mao, S.; Rosner, S.; Forde, P. M.; Chaft, J. E.; Jones, D. R.; Spicer, J.; Hales, R. K.; Ha, J. S.; Hu, C.; Voong, K. R.
    Clinical Lung Cancer (2024)

    Fulltext@MSK | Save
  • Real-world outcomes in non-small-cell lung cancer patients with MET Exon 14 skipping mutation and brain metastases treated with capmatinib
    Journal Article

    Paik, P. K.; Goyal, R. K.; Cai, B.; Price, M. A.; Davis, K. L.; Ansquer, V. D.; Caro, N.; Saliba, T. R.
    Future Oncology (2023)

    Fulltext@MSK | Save
  • LIBRETTO-432, a phase III study of adjuvant selpercatinib or placebo in stage IB-IIIA RET fusion-positive non-small-cell lung cancer
    Review

    Tsuboi, M.; Goldman, J. W.; Wu, Y. L.; Johnson, M. L.; Paz-Ares, L.; Yang, J. C. H.; Besse, B.; Su, W.; Chao, B. H.; Drilon, A.
    Future Oncology (2022)

    Fulltext@MSK | Save
  • Encorafenib plus binimetinib in patients with BRAF(V600)-mutant non-small cell lung cancer: Phase II PHAROS study design
    Journal Article

    Riely, G. J.; Ahn, M. J.; Felip, E.; Ramalingam, S. S.; Smit, E. F.; Tsao, A. S.; Alcasid, A.; Usari, T.; Wissel, P. S.; Wilner, K. D.; more...
    Future Oncology (2022)

    Fulltext@MSK | Save